key focus areas – Globalization

MDS continues to expand its global footprint in key geographies to better meet current and emerging customer needs, and to gain access to growth markets in rapidly developing regions.

Opportunity in Asia
In 2008, MDS Pharma Services moved its Singapore Central Lab operation to a new, larger facility, enabling the contract research organization to better meet the current and emerging needs of its clients in the Asia-Pacific region. The new facility, which is located in the Marsiling Industrial Park, has twice the previous capacity for sample storage, processing and safety testing. MDS Pharma Services has seen its sample volume in Singapore double in the past year.

			Glucotrace: MDS plans to expand operations in Belgium to meet growing demand for its Glucotrace imaging agent, one of the most often-used positron emission tomography isotopes for cardiology and oncology diagnoses.